Change in Cardiovascular Health Metrics and Risk for Proteinuria Development: Analysis of a Nationwide Population-Based Database.
Cardiovascular health metrics
Epidemiology
Proteinuria
Journal
American journal of nephrology
ISSN: 1421-9670
Titre abrégé: Am J Nephrol
Pays: Switzerland
ID NLM: 8109361
Informations de publication
Date de publication:
2022
2022
Historique:
received:
04
12
2021
accepted:
04
01
2022
pubmed:
9
3
2022
medline:
8
4
2022
entrez:
8
3
2022
Statut:
ppublish
Résumé
Evidence is lacking regarding the association between cardiovascular health (CVH) metrics and the risk for proteinuria. We performed this observational cohort study including 865,087 participants (median age, 46 years, 60.7% men) with negative proteinuria at the initial health check-up, who underwent repeated health check-ups within 4 years. Ideal CVH metrics included nonsmoking, body mass index <25 kg/m2, physical activity at goal, eating breakfast, blood pressure <120/80 mm Hg, fasting plasma glucose <100 mg/dL, and total cholesterol <200 mg/dL. The primary outcome was incident proteinuria, defined as ≥1 + on the urine dipstick test. Participants were categorized as having low CVH metrics defined as having 0-2 ideal CVH metrics (n = 84,439), middle CVH metrics defined as having 3-4 ideal CVH metrics (n = 335,773), and high CVH metrics defined as having 5-7 ideal CVH metrics (n = 444,875). Compared with low CVH metrics, middle CVH metrics (odds ratio (OR): 0.61, 95% CI: 0.59-0.63) and high CVH metrics (OR: 0.45, 95% CI: 0.43-0.46) were associated with a lower risk of proteinuria. The OR of a one-point increase in the ideal number of CVH metrics was 0.83 (95% CI: 0.82-0.83). All CVH metrics components except for ideal total cholesterol were associated with a decreased risk of proteinuria. A one-point improvement in the number of ideal CVH metrics at 1 year after the initial health check-up was associated with a decreased incidence of proteinuria (OR: 0.90, 95% CI: 0.89-0.92). Not only maintaining better CVH metrics but also improving CVH metrics would prevent developing proteinuria in a general population.
Identifiants
pubmed: 35259741
pii: 000522147
doi: 10.1159/000522147
pmc: PMC9116600
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
240-248Informations de copyright
© 2022 The Author(s). Published by S. Karger AG, Basel.
Références
Kidney Int. 2002 Nov;62(5):1743-9
pubmed: 12371975
Scientifica (Cairo). 2014;2014:253581
pubmed: 24982814
Kidney Int Rep. 2017 Jan 23;2(2):251-260
pubmed: 29142961
Ann Intern Med. 2020 Sep 15;173(6):426-435
pubmed: 32658569
Clin Exp Nephrol. 2018 Oct;22(5):1133-1142
pubmed: 29600409
J Am Coll Cardiol. 2017 Jun 27;69(25):3015-3026
pubmed: 28641790
Br J Sports Med. 2015 Feb;49(4):255-8
pubmed: 24550208
Clin Exp Nephrol. 2020 Feb;24(2):151-156
pubmed: 31734818
Eur J Clin Nutr. 2021 Mar;75(3):531-538
pubmed: 32994554
J Am Coll Cardiol. 2020 Nov 17;76(20):2414-2416
pubmed: 33183514
Epidemiology. 2016 Jan;27(1):91-7
pubmed: 26484424
J Nephrol. 2021 Jun;34(3):719-728
pubmed: 32852701
J Atheroscler Thromb. 2021 May 1;28(5):535-543
pubmed: 32863289
JAMA. 2012 Mar 28;307(12):1273-83
pubmed: 22427615
Arch Intern Med. 2006 Apr 24;166(8):884-9
pubmed: 16636214
Burns. 2018 Dec;44(8):1954-1961
pubmed: 29980328
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Kidney Int. 2007 Jan;71(2):159-66
pubmed: 17136030
Circulation. 2010 Feb 23;121(7):948-54
pubmed: 20177011
J Am Soc Nephrol. 2021 Jan;32(1):239-253
pubmed: 32868398
Eur Heart J Qual Care Clin Outcomes. 2020 Apr 1;6(2):138-146
pubmed: 31328232
Atherosclerosis. 2021 Feb;319:35-41
pubmed: 33465660
Environ Health Prev Med. 2016 May;21(3):129-37
pubmed: 26797823
Clin Chem. 1972 Jun;18(6):499-502
pubmed: 4337382
Nephrol Dial Transplant. 2021 May 27;36(6):1039-1048
pubmed: 33247759
Clin J Am Soc Nephrol. 2008 Jan;3(1):226-36
pubmed: 18003763
J Am Soc Nephrol. 2001 Jun;12(6):1211-1217
pubmed: 11373344
Kidney Int. 2011 Jul;80(1):93-104
pubmed: 21289597
Circulation. 2005 Aug 16;112(7):969-75
pubmed: 16087792
Circulation. 2021 Jun 8;143(23):2244-2253
pubmed: 33886370
Clin J Am Soc Nephrol. 2011 Oct;6(10):2462-9
pubmed: 21885794